1828 related articles for article (PubMed ID: 28720732)
1.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
Orazi G; Ruoff KL; O'Toole GA
mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
[No Abstract] [Full Text] [Related]
3. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.
Orazi G; Jean-Pierre F; O'Toole GA
J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077
[TBL] [Abstract][Full Text] [Related]
4. Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.
Price CE; Brown DG; Limoli DH; Phelan VV; O'Toole GA
J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31792010
[TBL] [Abstract][Full Text] [Related]
5. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.
Barraza JP; Whiteley M
mBio; 2021 Mar; 12(2):. PubMed ID: 33785630
[No Abstract] [Full Text] [Related]
6. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.
Filkins LM; Graber JA; Olson DG; Dolben EL; Lynd LR; Bhuju S; O'Toole GA
J Bacteriol; 2015 Jul; 197(14):2252-64. PubMed ID: 25917910
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus.
Radlinski L; Rowe SE; Kartchner LB; Maile R; Cairns BA; Vitko NP; Gode CJ; Lachiewicz AM; Wolfgang MC; Conlon BP
PLoS Biol; 2017 Nov; 15(11):e2003981. PubMed ID: 29176757
[TBL] [Abstract][Full Text] [Related]
8. Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients.
Fugère A; Lalonde Séguin D; Mitchell G; Déziel E; Dekimpe V; Cantin AM; Frost E; Malouin F
PLoS One; 2014; 9(1):e86705. PubMed ID: 24466207
[TBL] [Abstract][Full Text] [Related]
9. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
10.
Limoli DH; Whitfield GB; Kitao T; Ivey ML; Davis MR; Grahl N; Hogan DA; Rahme LG; Howell PL; O'Toole GA; Goldberg JB
mBio; 2017 Mar; 8(2):. PubMed ID: 28325763
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
[No Abstract] [Full Text] [Related]
13.
Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
[No Abstract] [Full Text] [Related]
14. Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide.
Mitchell G; Séguin DL; Asselin AE; Déziel E; Cantin AM; Frost EH; Michaud S; Malouin F
BMC Microbiol; 2010 Jan; 10():33. PubMed ID: 20113519
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection.
Baldan R; Cigana C; Testa F; Bianconi I; De Simone M; Pellin D; Di Serio C; Bragonzi A; Cirillo DM
PLoS One; 2014; 9(3):e89614. PubMed ID: 24603807
[TBL] [Abstract][Full Text] [Related]
16. Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.
Tavernier S; Crabbé A; Hacioglu M; Stuer L; Henry S; Rigole P; Dhondt I; Coenye T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696232
[TBL] [Abstract][Full Text] [Related]
17. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
Chen X; Thomsen TR; Winkler H; Xu Y
BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
[TBL] [Abstract][Full Text] [Related]
18. Anaerobiosis influences virulence properties of Pseudomonas aeruginosa cystic fibrosis isolates and the interaction with Staphylococcus aureus.
Pallett R; Leslie LJ; Lambert PA; Milic I; Devitt A; Marshall LJ
Sci Rep; 2019 May; 9(1):6748. PubMed ID: 31043640
[TBL] [Abstract][Full Text] [Related]
19. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
[TBL] [Abstract][Full Text] [Related]
20. Iron Depletion Enhances Production of Antimicrobials by Pseudomonas aeruginosa.
Nguyen AT; Jones JW; Ruge MA; Kane MA; Oglesby-Sherrouse AG
J Bacteriol; 2015 Jul; 197(14):2265-75. PubMed ID: 25917911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
